Welcome international healthcare professionals

Welcome, this website is intended for healthcare professionals with an interest in the ECC Webcasts. By clicking the button below you are declaring and confirming that you are a healthcare professional.

You are here

The why, the which, and the how of targeting angiogenesis in GI malignancies

Mon 28 Sept / 19:00 – 20:30 / Hall A2

Official Sponsored Satellite Symposium at European Cancer Congress 2015 - Monday 28 September 2015

Angiogenesis plays an important role in the progression of gastrointestinal (GI) malignancies. Anti-angiogenic treatments have improved the overall survival of patients with these cancers. The introduction of new anti-angiogenic agents warrants both exploration of the latest clinical data and discussion on how treatments involving anti-angiogenic drugs can be used to optimize outcomes in this patient group.


Presentations

Search this site

Search form

E-Alert

Register to our E-Alert to stay informed of new clinical research and cases published on this platform.

Share